Market closedNon-fractional
Edgewise Therapeutics/EWTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Edgewise Therapeutics
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Ticker
EWTX
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Boulder, United States
Employees
92
Website
www.edgewisetx.com
EWTX Metrics
BasicAdvanced
$2B
Market cap
-
P/E ratio
-$1.52
EPS
0.16
Beta
-
Dividend rate
Price and volume
Market cap
$2B
Beta
0.16
Financial strength
Current ratio
37.084
Quick ratio
36.49
Long term debt to equity
0.797
Total debt to equity
0.981
Management effectiveness
Return on assets (TTM)
-17.14%
Return on equity (TTM)
-24.51%
Valuation
Price to book
3.71
Price to tangible book (TTM)
3.71
Price to free cash flow (TTM)
-14.874
Growth
Earnings per share change (TTM)
14.53%
3-year earnings per share growth (CAGR)
-57.81%
What the Analysts think about EWTX
Analyst Ratings
Majority rating from 6 analysts.
EWTX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$29M
-5.32%
Profit margin
0.00%
NaN%
EWTX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
-$0.41
-$0.47
-$0.33
-
Expected
-$0.40
-$0.40
-$0.43
-$0.39
-$0.35
Surprise
-14.57%
3.54%
8.29%
-15.82%
-
EWTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Edgewise Therapeutics stock?
Edgewise Therapeutics (EWTX) has a market cap of $2B as of July 25, 2024.
What is the P/E ratio for Edgewise Therapeutics stock?
The price to earnings (P/E) ratio for Edgewise Therapeutics (EWTX) stock is 0 as of July 25, 2024.
Does Edgewise Therapeutics stock pay dividends?
No, Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders as of July 25, 2024.
When is the next Edgewise Therapeutics dividend payment date?
Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Edgewise Therapeutics?
Edgewise Therapeutics (EWTX) has a beta rating of 0.16. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Edgewise Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.